The nanotechnology invented and developed in the Professor Khizroev group in the collaboration with Professor Carolyn Runowicz at Florida International University and Professor Ping Liang at the University of California resulted in a breakthrough in the treatment of ovarian cancer: a novel way to deliver cancer-killing drugs using nanotechnology. The invention can be applied to a broad range of cancers including breast and lung cancers. Khizroev, Ph.D., a Fellow of National Academy of Inventors, is a Professor of Electrical Engineering at the College of Engineering and Computing and Director of the university-wide Center for Personalized Nanomedicine. Runowicz, M.D., is a Professor of Gynecology and Obstetrics and Executive Dean for Academic Affairs at the Herbert Wertheim College of Medicine. Runowicz, an ex-President of American Cancer Society, specializes in treating ovarian cancer, the deadliest of all gynecological cancers. PhD Candidate Rakesh Guduru designed and conducted all the key experiments in this cross-disciplinary and multi-campus effort. The main findings of the research were described in a recent article in Scientific Reports, the multidisciplinary open-access journal of Nature Publication Group.
This article was showcased in numerous major news media in medical and engineering communities across the globe, including the famous IEEE Spectrum and the prestigious article collection of The Latest Science.